BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang L, Kamat M, Shukla A, Vora M, Kalal C, Kottilil S, Shah S. Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C. Interdiscip Perspect Infect Dis 2018;2018:9124604. [PMID: 30364048 DOI: 10.1155/2018/9124604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Garcia A, Moore Boffi S, Gayet-Ageron A, Vernaz N. Access to unauthorized hepatitis C generics: Perception and knowledge of physicians, pharmacists, patients and non-healthcare professionals. PLoS One 2019;14:e0223649. [PMID: 31600328 DOI: 10.1371/journal.pone.0223649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Anand A, Shalimar. Hepatitis C virus in India: Challenges and Successes. Clin Liver Dis (Hoboken) 2021;18:150-4. [PMID: 34691402 DOI: 10.1002/cld.1137] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]